Ispire Technology (ISPR) investor relations material

Executive summary

• Revenue for Q2 2026 was $20.3 million, down 51.5% year-over-year, driven by a strategic shift away from lower-value cannabis customers and a focus on high-quality nicotine sector clients.

• Net loss improved to $6.6 million from $8.0 million year-over-year, reflecting cost-cutting and efficiency initiatives.

• Gross margin declined to 17.1% from 18.5% year-over-year, primarily due to a less favorable product mix.

• Operating expenses dropped to $10.3 million from $15.1 million, highlighting disciplined cost controls, especially in North America.

• Strategic pivot to Malaysia for production aligns with rising costs in China and global nicotine sector trends.

Financial highlights

• Revenue for Q2 2026 was $20.3 million, down from $41.8 million year-over-year; six-month revenue was $50.6 million, down from $81.2 million.

• Gross profit was $3.5 million, with gross margin at 17.1%.

• Net loss for the quarter was $6.6 million ($0.12 per share), compared to $8.0 million ($0.14 per share) year-over-year.

• Operating expenses for the quarter were $10.3 million, down from $15.1 million year-over-year.

• Cash and cash equivalents at quarter-end were $17.6 million; working capital stood at $3.5 million.

Outlook and guidance

• Management expects continued improvement in cost management, accounts receivable, and net loss through fiscal 2026, with future quarters showing top-line growth and bottom-line improvement.

• Ongoing ramp-up of manufacturing in Malaysia and momentum in proprietary G-Mesh technology are expected to drive growth.

• Management expects current cash and cash flows from operations, along with proceeds from recent equity offerings and borrowings, to be sufficient for working capital needs over the next 12 months.

• Additional financing may be required if adverse conditions arise or if growth is accelerated.